NRx Pharmaceuticals, Inc. (NRXP)
USD 1.55
(-5.79%)
USD 1.55
(-5.79%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 5000.00 | 4000.00 | 2000.00 | 907.4 Thousand | - | 1 Million |
| Gross Profit | -5000.00 | -4000.00 | -2000.00 | -907.4 Thousand | - | -1 Million |
| Operating Expenses | 27.58 Million | 44.39 Million | 94.43 Million | 11.9 Million | 6426.10 | 1 Million |
| Selling, General and Administrative Expenses | 14.21 Million | 27.37 Million | 74.94 Million | 11.43 Million | 2767.59 | 1 Million |
| Research and Development Expenses | 13.37 Million | 17.02 Million | 20.25 Million | 10.62 Million | 3495.65 | - |
| Other Expenses | - | -505 Thousand | -771 Thousand | -10.16 Million | 713.18 Thousand | 1 Million |
| Cost and Expenses | 27.58 Million | 44.39 Million | 94.43 Million | 11.9 Million | 6426.10 | 1 Million |
| Operating Income | -27.58 Million | -44.39 Million | -115.79 Million | -51.38 Million | -6263.24 | -1 Million |
| Interest Expense | 120 Thousand | - | 18 Thousand | 56 Thousand | - | - |
| Income Tax Expense | -9000.00 | -4.58 Million | -21.34 Million | -39.43 Million | 84.2 Thousand | 16.31 Thousand |
| Earnings before Tax | -30.15 Million | -39.81 Million | -93.06 Million | -51.77 Million | 492.63 Thousand | 82.41 Thousand |
| Net Income | -30.15 Million | -35.23 Million | -71.71 Million | -12.34 Million | 408.42 Thousand | 66.1 Thousand |
| Earnings Per Share Basic | -3.98 | -0.54 | -1.53 | -0.36 | 0.80 | 0.07 |
| Earnings Per Share Diluted | -3.98 | -0.54 | -1.53 | -0.36 | 0.80 | 0.07 |
| Weighted Average Shares Outstanding | 7.57 Million | 65.76 Million | 46.91 Million | 34.27 Million | 508.83 Thousand | 892.49 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 7.57 Million | 65.76 Million | 46.91 Million | 34.27 Million | 508.83 Thousand | 892.49 Thousand |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -30.02 Million | -39.75 Million | -93.04 Million | -51.71 Million | -713.18 Thousand | 82.41 Thousand |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | 8000.00 | - | - |
| Cost of Revenue | 1000.00 | 1000.00 | 5000.00 | 1000.00 | 2000.00 | 1000.00 |
| Gross Profit | -1000.00 | -1000.00 | -5000.00 | 7000.00 | -2000.00 | -1000.00 |
| Operating Expenses | 7.04 Million | 5.99 Million | 27.58 Million | 4.4 Million | 5.8 Million | 7.93 Million |
| Selling, General and Administrative Expenses | 4.24 Million | 4.24 Million | - | 1.87 Million | 2.49 Million | 4.06 Million |
| Research and Development Expenses | 2.8 Million | 1.74 Million | - | 2.53 Million | 3.31 Million | 3.87 Million |
| Other Expenses | -849 Thousand | - | 250 Thousand | 2.27 Million | - | -250 Thousand |
| Cost and Expenses | 7.05 Million | 5.99 Million | 27.58 Million | 4.4 Million | 5.8 Million | 7.93 Million |
| Operating Income | -7.05 Million | -5.99 Million | -27.58 Million | -4.4 Million | -5.8 Million | -8.18 Million |
| Interest Expense | - | 230 Thousand | 120 Thousand | 80 Thousand | 40 Thousand | - |
| Income Tax Expense | - | -42.27 Thousand | - | -1.39 Million | 40 Thousand | -250 Thousand |
| Earnings before Tax | -7.89 Million | -6.52 Million | -30.15 Million | -4.33 Million | -6.06 Million | -8.71 Million |
| Net Income | -7.89 Million | -6.52 Million | -30.15 Million | -4.33 Million | -6.06 Million | -8.71 Million |
| Earnings Per Share Basic | -0.75 | -0.74 | - | -0.05 | -0.07 | -0.12 |
| Earnings Per Share Diluted | -0.75 | -0.74 | - | -0.05 | -0.07 | -0.12 |
| Weighted Average Shares Outstanding | 10.51 Million | 8.85 Million | 7.57 Million | 83.91 Million | 81.94 Million | 73.22 Million |
| Weighted Average Shares Outstanding (Diluted) | 10.51 Million | 8.85 Million | 7.57 Million | 83.91 Million | 81.94 Million | 73.22 Million |
| Gross Margin | - | - | - | 0.88 | - | - |
| EBIT Margin | - | - | - | -550.62 | - | - |
| Profit Margin | - | - | - | -541.50 | - | - |
| EBITDA | -7.04 Million | -5.99 Million | - | -4.4 Million | -5.68 Million | -8.04 Million |
| Earnings Before Tax Margin | - | - | - | -550.75 | - | - |
0HYJ
NWBI
1949
MTC
TSGTF
002690